Mcrae Capital Management Inc Novo Nordisk A S Transaction History

Mcrae Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$47.54 - $53.43 $223,438 - $251,121	-4,700 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$46.36 - $52.63 $113,582 - $128,943	-2,450 Reduced 34.27%	4,700 $246,000
Q4 2018 Jan 28, 2019	SELL	$41.54 - $47.25 $166,160 - $189,000	-4,000 Reduced 35.87%	7,150 $329,000
Q3 2018 Oct 15, 2018	SELL	$46.76 - $51.24 $11,690 - $12,810	-250 Reduced 2.19%	11,150 $526,000
Q1 2018 May 09, 2018	SELL	$48.49 - $58.14 $48,490 - $58,140	-1,000 Reduced 8.06%	11,400 $561,000

Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $224,103 - $253,336	-4,715 Reduced 27.55%	12,400 $666,000
Q3 2017 Oct 23, 2017	BUY	$41.15 - $49.22 $704,282 - $842,400	17,115	17,115 $824,000

1,859

310M

5.29M

4.93M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $321B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Mcrae Capital Management Inc with notifications on news.